mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.8 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |